{
  "data": {
    "indicator": {
      "slug": "rare-diseases-treatment-availability-rate",
      "name": "Rare diseases treatment availability rate",
      "definition": "Percentage of recognized rare diseases for which at least one approved therapeutic treatment exists.",
      "unit": "percent",
      "scale": "1",
      "default_unit": "percent",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "percent",
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "points": [
      {
        "period_start": "2025-01-01",
        "period_label": "end of 2025",
        "value": 5,
        "scale": "1",
        "unit": "percent",
        "value_type": "estimate",
        "statistic_id": "stat_3G0PECR75YC670M97PDAEJET36",
        "url": "https://statorigin.org/stat/stat_3G0PECR75YC670M97PDAEJET36",
        "source_org": "PhRMA",
        "source": {
          "org": "PhRMA",
          "org_short_name": "PhRMA",
          "document_title": "Research & Development",
          "document_url": "https://phrma.org/policy-issues/research-development",
          "locator": "Progress toward New Medicines and Vaccines",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "GLOBAL"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}